top of page
.png)
The EU's Leading Role on Supporting Antimicrobial R&D and Access
Antimicrobial therapeutics have extremely high societal value and investing in a strong R&D ecosystem and market offers an opportunity to...
ARMoR
Dec 10, 20241 min read
Introduction to the UK Antimicrobial Subscription Model
The " UK Antimicrobial subscription model " is the world's first, and currently only, pull incentive for antimicrobial development. The...
David McKinney
Nov 7, 20241 min read
Taking Action on Pull Incentives in Sweden
Key Messages: Antimicrobial Resistance is a growing health concern, both across the globe where it is attributed with 1.27 million deaths...
Aanika Dalal
Sep 16, 20242 min read
Taking Action on Pull Incentives in Norway
Key Messages: Antimicrobial resistance is a growing health concern, both across the globe where it is attributed with 1.27 million deaths...
Aanika Dalal
Sep 4, 20241 min read
Estimating the Return on Investment of Pull Incentive Policies for New Antimicrobials: Insights for the EU and Beyond
Key Messages:Â Antimicrobial resistance is an increasing global threat and the world needs a reliable pipeline of new, effective...
Aanika Dalal
Jul 15, 20241 min read
Think7 Policy Recommendations for the 2024 G7 Summit in Italy
With the G7 Leaders Summit currently underway in Italy, ARMoR in collaboration with the Global Antibiotic Research and Development...
Aanika Dalal
Jun 14, 20244 min read
Taking Action on Pull Incentives: Estimating the Return on Investment for Incentivising New Antimicrobials in Denmark
Key Messages: Antimicrobial Resistance is a growing health concern, both globally and in Denmark, and is associated with an estimated...
ARMoR
May 2, 20241 min read
bottom of page